The Future Is Now


Read Article


Visit @GlaucomaToday on Twitter

Articles From This Issue


The Future Is Now


Diagnostic Testing

As a medical subspecialty, glaucoma is unique in several ways. One of the less flattering particularities of our field is our inability to characterize the disease’s…

The Gift of Mentorship


Recently, I was reflecting on how blessed I have been. I am a man of humble beginnings who grew up in Flandreau, South Dakota. My father served our small rural community a…

The Literature


Discrimination of Glaucoma Patients From Healthy Individuals Using Combined Parameters From Spectral-Domain Optical Coherence Tomography in an African American Population …


GlaucomaToday Polls

View All



EyeGate Announces Interim Data from Clinical Trial of EGP-437 for Treatment of I…

EyeGate Pharmaceuticals announced interim data from its phase 1b/2a trial evaluating its lead produc…

Femtosecond Laser Could Help in Challenging Cataract Cases

Cataract patients with shallow anterior chambers who were treated with femtosecond laser-assisted ca…

Video Series

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Facebook Twitter

About Glaucoma Today

Glaucoma Today is mailed bimonthly (six times a year) to 11,519 glaucoma specialists, general ophthalmologists, and clinical optometrists who treat patients with glaucoma. Glaucoma Today delivers important information on recent research, surgical techniques, clinical strategies, and technology.